Ismail Erturk - Department of Medical Oncology, Gülhane Training and Research Hospital

基本信息

Career Trajectory

Bio

Ismail Erturk currently works at the Division of Internal Medicine, Gulhane Military Medical Academy. Ismail does research in Oncology, Nephrology and Hematology. Their most recent publication is 'Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes'.

Research Interests

Papers共 93 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Salvage Therapy of Relapsed/Refractory Germ Cell Tumors: A Single-Center Experience

Gul Sema Yildiran Keskin,Ismail Erturk,Musa Baris Aykan,Ramazan Acar,Aysegul Dumludag,Alper Topal,Caglar Koseoglu,Omer Faruk Kuzu,Ece Ornek,Nuri Karadurmus

Oncology Research and Treatmentpp.1-10, (2024)

Cited0Views0WOSBibtex

Efficacy and Safety of Bevacizumab in Patients with Low-Grade Serous Ovarian Cancer

Cengiz Karacin,Veli Sunar,Zuhat Urakci,Ali Yilmaz,Murat Ayhan, Mustafa Ersoy,Deniz Can Guven,Ismail Erturk,Yasin Durmus,Pinar Karacin,Nurettin Boran,Yaprak Engin Ustun, Mutlu Meydan,Mutlu Dogan,Berna Oksuzoglu,Ozturk Ates,Mustafa Karaca,Dogan Uncu,Yakup Ergun,Zafer Arik

FUTURE ONCOLOGYno. 4 (2024): 207-214

Cited0Views0WOSBibtex

The Role of High Dose Chemotherapy with Autologous Hematopoietic Cell Transplant in Relapsed/Refractory Ovarian Germ Cell Tumors: A Single Center Experience

Alper Topal,Ismail Erturk,Caglar Koseoglu,Aysegul Dumludag,oemer Faruk Kuzu, Pelin Durmaz,Goncagul Akdag,Gul Sema Yildiran Keskin,Nuri Karadurmus

CLINICAL GENITOURINARY CANCERno. 4 (2024)

Cited0Views0WOSBibtex

702P Survival and Related Factors in Testicular Non-Seminomatous Patients Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplantation: Experience of Turkey's Highest Volume Transplantation Center

M.B. Aykan,I. Erturk,R. Acar, G.S.Y. Keskin, A.F. Kose,N. Karadurmus

Annals of Oncology (2024)

Cited0Views0Bibtex

Treatment Options in Primary Mediastinal B Cell Lymphoma Patients, Retrospective Multicentric Analysis; a Turkısh Oncology Group Study

Journal of Cancer Research and Therapeutics/Journal of cancer research and therapeuticsno. 8 (2023): 138-138

Cited0Views0WOSBibtex

Electrophoresis Testing in the Follow-up of Multiple Myeloma Patients with a Measurable M Protein in Gamma Region: Good Laboratory Practice for the Laboratory Specialist

Özgür Aydın,İsmail Ertürk

LLM Dergino. 2 (2023): 82-85

Cited0Views0Bibtex

443P Efficacy and Safety of CDK 4/6 Inhibitors in Patients with Bone Marrow-Involved Metastatic Breast Cancer

C. Karacin,F. Aslan, A. Dumludag, A. Alkan, M. Türker,K. Bir Yucel, E. Mutlu,S. Kahraman,M. Ayhan,O.U. Unal,A. Türkel,Y. Iriagac, E. Aydin, Y. Ergün,N. Karadurmus,O. Ates,O. Yazici,S. Paydas,I. Erturk

Annals of Oncology (2023): S368

Cited0Views0Bibtex

Gama Alanında Ölçülebilir M Protein İçeren Multipl Miyelom Hastalarının Elektroforez Ile Takibi: Laboratuvar Uzmanları İçin İyi Laboratuvar Uygulamaları

Özgür Aydın,İsmail Ertürk

LLM Dergino. 2 (2023): 82-85

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn